Evidence map›Paper›PMID 41007187›Full record

ReviewBioengineering (Basel, Switzerland)2025

Superior Capsule Reconstruction Graft Selection: The Influence of Biological Properties of Grafts on Healing and Re-Tearing.

Mingde Cao, Mingguang Bi, Shuai Yuan, Yuhao Wu, Patrick Shu-Hang Yung, Michael Tim-Yun Ong

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingde CaoDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Shatin, Hong Kong SAR, China.ORCID 0000-0003-1445-7856
Mingguang BiDepartment of Joint and Sports Medicine, The Affiliated Lihuili Hospital, Ningbo University, Ningbo 315211, China.
Shuai YuanDepartment of Sport Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510515, China.
Yuhao WuDepartment of Sport Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510515, China.
Patrick Shu-Hang YungDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Shatin, Hong Kong SAR, China.
Michael Tim-Yun OngDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Shatin, Hong Kong SAR, China.ORCID 0000-0002-4460-9286

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arthroscopic Superior Capsular Reconstruction has emerged as a promising surgical intervention for irreparable massive rotator cuff tears, aiming to restore glenohumeral joint stability and improve patient outcomes. A critical determinant of ASCR success is the selection of an appropriate graft material. This review explores the spectrum of grafts utilized in ASCR, including autografts, allografts, xenografts, and synthetic materials. The primary focus is on how the inherent biological properties of these grafts-such as cellularity, vascularity, immunogenicity, and extracellular matrix composition-profoundly influence the processes of graft healing, integration into host tissues, and ultimately, the rates of re-tearing. Autografts, particularly fascia lata, often demonstrate superior biological incorporation due to their viable cells and non-immunogenic nature, leading to high healing rates. Allografts, while offering advantages like reduced donor site morbidity, present biological challenges related to decellularization processes and slower remodeling, resulting in more variable healing outcomes. Xenografts face significant immunological hurdles, often leading to rejection and poor integration. Synthetic grafts provide an off-the-shelf option but interact with host tissue primarily as a scaffold, without true biological integration. Understanding the nuanced biological characteristics of each graft type is paramount for surgeons aiming to optimize healing environments and minimize re-tear rates, thereby enhancing the long-term efficacy of ASCR.

Indexed as

autograftgraft healingsuperior capsule reconstruction

Identifiers

PMID41007187
PMCPMC12467298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.